Skip to main content
Clinical Trials/IRCT20200606047668N1
IRCT20200606047668N1
Recruiting
Phase 3

Randomized controlled trial metabolic effects of adding Topiramate on Aripiprazole in bipolar patients under age 18

Esfahan University of Medical Sciences0 sites38 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
38
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Consent to participate in the study by completing the informed consent form by patient and family.
  • Lack of any chronic physical illness.
  • Negative history of recieving any antypsychotic drug or mood stabilizers or drugs that could change appetite during recent 3 month before study
  • Lack of history of allergic reaction to topiramate
  • Lack of history of renal insufficiency or renal stone
  • Age between 6\-18 years

Exclusion Criteria

  • patient or family unwillingness to stay in study
  • Need to ECT treatment during study
  • Any unexpected new physical illness that could change medical care of patient

Outcomes

Primary Outcomes

Not specified

Similar Trials